MAPT and Alzheimer disease: Weigand et al. report that a group of older adults with PET evidence of tau in the absence of amyloid-beta demonstrate clinical, cognitive and biomarker characteristics that are consistent with groups traditionally considered to be on the Alzheimer’s disease continuum.